v3.26.1
Acquisitions (Additional Information) (Details) - USD ($)
$ / shares in Units, $ in Thousands
1 Months Ended 3 Months Ended 12 Months Ended
Dec. 05, 2025
Aug. 30, 2024
Jun. 14, 2022
Jan. 31, 2026
Mar. 31, 2026
Mar. 31, 2025
Dec. 31, 2025
Mar. 02, 2026
Jan. 20, 2026
Apr. 17, 2025
Jun. 18, 2024
Business Combination [Line Items]                      
Common stock, par value         $ 0.0001   $ 0.0001 $ 0.68      
Payment to acquire license         $ 100            
Common stock, shares issued         8,491,267   7,033,004       3,250,000
Fair Value of Assets Acquired $ 45,100                    
Liabilities Assumed $ 47,100                    
Royalty expenses         $ 0 $ 100          
Accrued Royalty Payables         $ 100   $ 200        
Sponsor Interest Purchase Agreement [Member]                      
Business Combination [Line Items]                      
Common stock, par value   $ 0.0001                  
Common stock, shares issued   8,571                  
Purchase of Class B shares   500,000                  
Cash consideration paid   $ 2,000,000                  
Vivasor Business Combination [Member] | Business Combination [Member]                      
Business Combination [Line Items]                      
Noncontrolling interest, Percentage 32.60%                    
Vivasor Business Combination [Member] | A-1 Preferred Stock | Business Combination [Member]                      
Business Combination [Line Items]                      
Business Combination, Price Per Share $ 0.00001                    
Agreed to purchase Stock 6,101,468                    
Aggregate purchase price of share $ 9,000                    
Vivasor Business Combination [Member] | A-2 Preferred Stock                      
Business Combination [Line Items]                      
Price Per Share         $ 1.97            
Cash consideration       $ 1,050              
Shah Agreement [Member] | A-2 Preferred Stock                      
Business Combination [Line Items]                      
Preferred Stock, Shares Issued                 254,228    
Preferred Stock, Redemption Amount                 $ 800    
Three I Fund Agreement [Member] | A-2 Preferred Stock                      
Business Combination [Line Items]                      
Preferred Stock, Shares Issued       101,691              
Preferred Stock, Redemption Amount       $ 300              
IPMC [Member] | Vivasor Business Combination [Member] | A-2 Preferred Stock | Business Combination [Member]                      
Business Combination [Line Items]                      
Agreed to purchase Stock       355,919              
Patents [Member]                      
Business Combination [Line Items]                      
Amount due for New Drug Application         $ 3,000            
Patents [Member] | Sorrento [Member]                      
Business Combination [Line Items]                      
Payment upon the achievement of net sales         20,000            
Scilex Bio JV [Member]                      
Business Combination [Line Items]                      
Common stock, shares issued                   5,000,000  
Scilex Bio JV [Member] | Semnur Merger Agreement And Sponsor Interest Purchase Agreement [Member]                      
Business Combination [Line Items]                      
Common stock, par value                   $ 0.00001  
License Agreement                      
Business Combination [Line Items]                      
Development milestones payment was recognized under other long-term liabilities         200   $ 200        
License Agreement | Romeg License Agreement [Member]                      
Business Combination [Line Items]                      
Payment upon the achievement of net sales     $ 13,000                
Royalty expenses         $ 200 $ 200